These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11873536)

  • 1. Acute pulmonary effects from o-chlorobenzylidenemalonitrile "tear gas": a unique exposure outcome unmasked by strenuous exercise after a military training event.
    Thomas RJ; Smith PA; Rascona DA; Louthan JD; Gumpert B
    Mil Med; 2002 Feb; 167(2):136-9. PubMed ID: 11873536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of the potent lacrimator o-chlorobenzylidene malononitrile (CS) tear gas.
    Anderson PJ; Lau GS; Taylor WR; Critchley JA
    Hum Exp Toxicol; 1996 Jun; 15(6):461-5. PubMed ID: 8793527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. O-chlorobenzylidene malononitrile (CS riot control agent) associated acute respiratory illnesses in a U.S. Army Basic Combat Training cohort.
    Hout JJ; White DW; Artino AR; Knapik JJ
    Mil Med; 2014 Jul; 179(7):793-8. PubMed ID: 25003867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. Marine Corps Amphibious Reconnaissance (Recon) students requiring hospitalization with pulmonary edema after strenuous exercise following exposure to o-chloro-benzylidenemalonitrile.
    McDonald EC; Mahon RT
    Mil Med; 2002 Nov; 167(11):iii-iv. PubMed ID: 12448609
    [No Abstract]   [Full Text] [Related]  

  • 5. Riot control agents: the tear gases CN, CS and OC-a medical review.
    Schep LJ; Slaughter RJ; McBride DI
    J R Army Med Corps; 2015 Jun; 161(2):94-9. PubMed ID: 24379300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of CS (o-chlorobenzylidene malononitrile) concentrations during U.S. Army mask confidence training.
    Hout JJ; Kluchinsky T; LaPuma PT; White DW
    J Environ Health; 2011 Oct; 74(3):18-21. PubMed ID: 22010329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RADS after exposure to a riot-control agent: a case report.
    Roth VS; Franzblau A
    J Occup Environ Med; 1996 Sep; 38(9):863-5. PubMed ID: 8877834
    [No Abstract]   [Full Text] [Related]  

  • 8. O-chlorobenzylidene malononitrile (CS riot control agent) exposure in a U.S. Army basic combat training cohort.
    Hout JJ; White DW; Stubner A; Stevens M; Knapik JJ
    J Environ Health; 2014 Oct; 77(3):14-21. PubMed ID: 25603650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between exposure to o-chlorobenzylidene malononitrile (CS riot control agent) and urinary metabolite 2-chlorohippuric acid in U.S. Army Mask Confidence Training.
    Buchanan MA; Stubner A; Hout JJ; Brueggemeyer M; Bragg W
    J Occup Environ Hyg; 2017 Sep; 14(9):712-719. PubMed ID: 28604270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contact allergy to CN and CS tear gas].
    Fuchs T; Ippen H
    Derm Beruf Umwelt; 1986; 34(1):12-4. PubMed ID: 2937623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is CS gas dangerous? Current evidence suggests not but unanswered questions remain.
    Fraunfelder FT
    BMJ; 2000 Feb; 320(7233):458-9. PubMed ID: 10678840
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of compounds formed during low temperature thermal dispersion of encapsulated o-chlorobenzylidene malononitrile (CS riot control agent).
    Hout JJ; Hook GL; Lapuma PT; White DW
    J Occup Environ Hyg; 2010 Jun; 7(6):352-7. PubMed ID: 20391049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe cutaneous reaction to CS gas.
    Varma S; Holt PJ
    Clin Exp Dermatol; 2001 May; 26(3):248-50. PubMed ID: 11422166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute mass burns caused by o-chlorobenzylidene malononitrile (CS) tear gas.
    Zekri AM; King WW; Yeung R; Taylor WR
    Burns; 1995 Dec; 21(8):586-9. PubMed ID: 8747730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can CS gas induce myocardial infarction?
    Zakhama L; Ben Ameur W; Antit S; Slama I; Jallad AE; Chenik S; Masmoudi M; Herbegue B; Boussabah E; Thameur M; Ben Youssef S
    Tunis Med; 2016 Oct; 94(8-9):626-628. PubMed ID: 28685801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical hazards of the tear gas CS. A case of persistent, multisystem, hypersensitivity reaction and review of the literature.
    Hill AR; Silverberg NB; Mayorga D; Baldwin HE
    Medicine (Baltimore); 2000 Jul; 79(4):234-40. PubMed ID: 10941352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can CS gas induce myocardial infarction?
    Zakhama L; Ben Ameur W; Antit S; Slama I; Jallad AE; Chenik S; Masmoudi M; Herbegue B; Boussabah E; Thameur M; Ben Youssef S
    Tunis Med; 2016 Oct; 94(10):626-628. PubMed ID: 28972257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of CS "tear gas" eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French Gendarmes.
    Viala B; Blomet J; Mathieu L; Hall AH
    J Emerg Med; 2005 Jul; 29(1):5-8. PubMed ID: 15961000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute laryngeal and bronchial obstruction after CS (o-chlorobenzylidenemalononitrile) gas inhalation.
    Karaman E; Erturan S; Duman C; Yaman M; Duman GU
    Eur Arch Otorhinolaryngol; 2009 Feb; 266(2):301-4. PubMed ID: 18365225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health risks of exposure to CS gas (tear gas): an update for healthcare practitioners in Hong Kong.
    Tsang ACO; Li LF; Tsang RKY
    Hong Kong Med J; 2020 Apr; 26(2):151-153. PubMed ID: 32300079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.